Welcome to Medizinisches Proteom-Center
Under the direction of Prof. Dr. Katrin Marcus, the Medizinische Proteom-Center is one of the world's leading institutes in proteome- and protein analysis. Its research interest covers all medical areas as well as natural scientific fundamentals. The methods used, include gel- and chromatography-based separation techniques with subsequent mass spectrometry, protein biochips and innovative bioinformatics.
News
University clinic Bochum fights against sepsis as cause of death
In the television program "Lokalzeit Ruhr" from March 22nd, 2018 PD Dr. Martin Eisenacher from the Medical Proteome-Center (MPC) and our cooperation partners PD Dr. Christian Stephan from Kairos Gmbh and Prof. Dr. Michael Adamzik from the university clinic "Knappschaftskrankenhaus" Bochum-Langendreer, gave an interview about the sepsis project. (see videos here soon)
Correct identification of liver cancer - RUBIN reports on MPC research
The origins of a tumour are relevant for correct treatment. Proteins provide a clue. Ruhr University Bochums science magazine reports on the work of the research group Clinical Proteomics at Medizinisches Proteom-Center. Learn more.
Das Wissenschaftsmagazin der Ruhr-Universität Bochum berichtet über die Forschung der Arbeitsgruppe Clinical Proteomics am Medizinischen Proteom-Center.
Talk with MPC Bioinformatics within the WDR5 Leonardo Radio Broadcast
About the topic AutoCorrection of GeneNames in supplements of scientific publications Aeneas T. Rooch from the WDR5 Leonardo team has interviewed Martin Eisenacher and others (excerpt about AutoCorrection: mp3 (in German); whole broadcast of 7th July 2017 in the Leonardo archive: mp3 (in German)).
NRW Project SepsisDataNet.NRW: Personalised Treatment of Sepsis
The Medical Proteome Center is part of the consortium SepsisDataNet.NRW and is working in central work packages with the topics Proteomics mass spectrometry and Bioinformatics. Aim of the 'Leitmarktagentur NRW / EFRE.NRW"-funded consortium SepsisDataNet.NRW - with participation of the two NRW companies AYYOXA GmbH and KAIROS GmbH - is the development of a sepsis bioassay and a decision support modul to treat sepsis patients in a personalised manner and to decrease the high letality of sepsis.
MPC is now offering MS services
For further information please contact Dr. Caroline May at caroline.may@rub.de and +49 234 32 24651
